TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to announce major changes to the country’s medical cannabis framework.  These could have a significant impact on the growth rate of Europe’s largest medical cannabis market, which has expanded in double-digits consistently since legalisation in 2017.  By potentially [...]

ANANDA Developments has today announced the acquisition of MRX Global in a deal set to transform the company’s offering.  The £2m acquisition deal will see the Aquis Stock Exchange-listed cultivator not only significantly accelerate its road to revenue generation, but also acquire the rights to a [...]

NORWAY, one of the most cautious states in Europe when it comes to cannabis liberalisation, recently held a public meeting to discuss access to medical cannabis.  The event, which took place in Oslo on January 20, 2023, brought together politicians from across the political spectrum, alongside [...]

LAST week a flurry of positive announcements from across the UK’s medical cannabis industry were unveiled in signs the industry is wasting no time in shaking off the stagnation of 2022.  Firstly, new data published by the government has provided the latest insight into the size [...]

KANABO announced the launch of two new additions to its range of VapePod formulas this week, in what is expected to be the first in a flurry of announcements due in the coming months.  The launch of two new high-THC formulas, which represent the second generation [...]

THE UK’s Medicines and Healthcare products Regulatory Agency (MHRA) last week released new detailed guidelines for medical cannabis companies operating in the UK.  This new guidance from the MHRA and the Home Office sought, for the first time, to provide a step-by-step plan for companies ‘that [...]

AS PLEA’s (Patient Lead Engagement for Access) Medical Cannabis Awareness Week (#MCAW2022) launches in the UK this week, fresh figures suggest growth in the number of privately prescribed, unlicensed medical cannabis items dispensed last year was even higher than previously thought. While growth is expected to [...]

GROW Group told BusinessCann back in 2020 that it was raising £6m in capital to fund its expansion across Europe, setting its sights on the German medical cannabis opportunity.  Nearly two years later and the company has now received its first orders from pharmacies for its [...]

ANANDA Developments has announced a number of heavyweight hires including a new COO, Head of Cultivation and Head of Plant Science, sending its stock price jumping nearly 30%.  Three months into its ‘first phase of operations’, which started nearly four years after it first listed on [...]

THE Isle of Man’s 83,000 inhabitants could soon gain access to medical cannabis for the first time as the Department of Health & Social Care (DHSC) prepares to launch a new pilot scheme.  On March 31 2022 the DHSC announced that it was looking to partner [...]

MGC Pharmaceutical has reported its strongest ever quarterly sales figures, but a lack of significant progress on its drug trials and regulatory approvals saw a muted response from investors.  The young Australian pharmaceuticals company, which is developing a number of cannabis-based drugs to treat Alzheimer’s, Dementia, [...]

GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.  The deal will allow the cultivator, which was established in 2019, to construct the ‘glasshouse’ facility and begin selling products by late next year, [...]

As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US. AFTER picking up their script from a health professional US medical cannabis consumers pop down to their local store for a chat with the bud tender on the [...]

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis medicine have emerged with news of the potential launch of a clinical trial. Ten patients will soon make history when they begin taking CannEpil+ – a high-CBD, [...]

ANANDA Developments has secured £300,000 to build out the first phase of its medicinal cannabis growing research facility in Lincolnshire. In May last year the AQSE Growth Market-listed business unveiled £12m plans to create one of the UK’s largest medicinal cannabis farms – capable of growing 300,000 [...]

Pierre Van Weperen of Grow Pharma on the post-Brexit issue surrounding the import of epilepsy cannabis medicines into the UK. MAINTAINING existing quality standards was one of the key themes of the Brexit argument and for finished medicines this still comes with a European Union Good [...]

THE NHS is to launch is first-ever cannabis patient registry in a move which signifies an ambition for the medicines to become more widely-available to UK patients. Health Secretary Matt Hancock ordered an urgent review into the lack of cannabis prescriptions, last spring. The creation of [...]